Diabetic nephropathy (DN) is an important healthcare challenge because it occurs in
about 40% of diabetic people and is a main cause end-stage renal disease. Toll like
receptor-4 (TLR-4) signaling is involved in DN incidence and progression through its
activation by hyperglycemia and hyperglycemia-induced alterations besides its crucial
roles in initiating inflammation and fibrosis in kidney. Syringic acid is a natural
phenolic acid. It is naturally available in many fruits and vegetables, including
swiss chards, grapes and olives. In this study, Reno protective effects of syringic
acid, as anti-inflammatory, anti-oxidant and anti-fibrotic natural compound, against
experimental DN were investigated. Streptozotocin (45mg/kg) was used in inducing rat
model of DN pathogenesis. In kidney homogenate, concentrations of TLR-4, interleukin-6
and transforming growth factor β1 (TGFβ1) were estimated by ELISA technique. Moreover,
hydroxyproline and relevant collagen content in kidney tissues were evaluated using
spectrophotometry. Oral administration of syringic acid (50 mg/kg) for 8 weeks succeeded
in keeping kidney function evidenced by significant decrease in serum levels of creatinine,
blood urea nitrogen (BUN) and decreased urinary protein content. Besides, it led to
significant increase in renal superoxide dismutase (SOD) activity and significant
decline in kidney malondialdehyde (MDA) content. Moreover, it showed significant anti-inflammatory
and anti-fibrotic effects reflected by significant decrease in levels of TLR-4, interleukin-6,
TGFβ1 and collagen in kidney homogenate as compared to DN group. Besides, it significantly
attenuated DN-induced histopathological deteriorations. In conclusion, syringic acid
can be proposed as an effective natural compound in halting DN progression through
inhibiting TLR-4 pathway resulting in ameliorating oxidative stress, inflammation
and fibrosis in kidney tissues.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Metabolism - Clinical and ExperimentalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect